Source link : https://newshealth.biz/health-news/fda-approves-first-treatment-for-mas-in-still-disease/
The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS) in known or suspected Still disease. This is the first FDA-approved treatment for MAS in the United States. The indication is specifically for adult and pediatric (newborn and older) patients with MAS in Still disease with an […]
The post FDA Approves First Treatment for MAS in Still Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-30 17:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8